The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Maintenance chemotherapy with pemetrexed in epiteliomorfe malignant pleural mesothelioma.
Angelo Nacci
No relevant relationships to disclose
Claudio Lotesoriere
No relevant relationships to disclose
Michele Montrone
No relevant relationships to disclose
Salvatore Pisconti
No relevant relationships to disclose
Laura Orlando
No relevant relationships to disclose
Palma Fedele
No relevant relationships to disclose
Pietro Rizzo
No relevant relationships to disclose
Nicola Calvani
No relevant relationships to disclose
Enrica Mazzoni
No relevant relationships to disclose
Margherita Cinefra
No relevant relationships to disclose
Antonella Marino
No relevant relationships to disclose
Francesco Sponziello
No relevant relationships to disclose
Saverio Cinieri
No relevant relationships to disclose